Performance and carcass characteristics of lambs fed diets containing different types of carbohydrates associated with polyunsaturated fatty acids

This study aimed to evaluate the productive performance and carcass characteristics of lambs fed diets with different types of carbohydrates associated with polyunsaturated fatty acids. Thirty castrated male lambs (20.5 ± 7.6 kg) were used, distributed in a randomized block design under three experimental diets: High proportion of non-fibrous carbohydrates (NFC) diet; High NFC diet + spineless cactus (high proportion of NFC and spineless cactus) and Low NFC diet (low proportion of NFC), in a 60 day experimental period. The variables of nutrient intake, performance, and carcass characteristics were evaluated. The animals fed the High NFC + spineless cactus diet presented a higher dry matter intake, organic matter, mineral matter, crude protein, and total carbohydrates intake (p <0.05). Carcass characteristics and weight of commercial cuts were improved in High NFC and High NFC + spineless cactus diets (p <0.05), on the other hand we observed a total fat weight reduction in animals fed with High NFC + spineless cactus. The results indicate that high levels of NFC positively influence animal performance, where the type of carbohydrate influences nutrient intake, also affecting carcass characteristics.(AU)

Growth curves in Down syndrome with congenital heart disease / Curvas de crescimento na síndrome de Down com cardiopatia congênita

SUMMARY Introduction: To assess dietary habits, nutritional status and food frequency in children and adolescents with Down syndrome (DS) and congenital heart disease (CHD). Additionally, we attempted to compare body mass index (BMI) classifications according to the World Health Organization (WHO) curves and curves developed for individuals with DS. Method: Cross-sectional study including individuals with DS and CHD treated at a referral center for cardiology, aged 2 to 18 years. Weight, height, BMI, total energy and food frequency were measured. Nutritional status was assessed using BMI for age and gender, using curves for evaluation of patients with DS and those set by the WHO. Results: 68 subjects with DS and CHD were evaluated. Atrioventricular septal defect (AVSD) was the most common heart disease (52.9%). There were differences in BMI classification between the curves proposed for patients with DS and those proposed by the WHO. There was an association between consumption of vitamin E and polyunsaturated fatty acids. Conclusion: Results showed that individuals with DS are mostly considered normal weight for age, when evaluated using specific curves for DS. Reviews on specific curves for DS would be the recommended practice for health professionals so as to avoid precipitated diagnosis of overweight and/or obesity in this population.

RESUMO Objetivo: avaliar hábitos alimentares, estado nutricional e frequência alimentar em crianças e adolescentes com síndrome de Down (SD) portadores de cardiopatia congênita (CC). Adicionalmente, procurou-se comparar classificações de índice de massa corpórea (IMC) de acordo com curvas da Organização Mundial da Saúde (OMS) e curvas desenvolvidas para indivíduos com SD. Método: estudo transversal com indivíduos portadores de SD e CC atendidos em um centro de referência para cardiologia, com idade entre 2 e 18 anos. Foram aferidos peso, altura, IMC, valor energético total (VET) e frequência alimentar. O estado nutricional foi analisado por meio de IMC para gênero e idade, utilizando-se curvas específicas para SD e curvas da OMS. Resultados: foram avaliados 68 indivíduos portadores de SD com CC. O defeito do septo atrioventricular (DSAV) foi a cardiopatia mais frequente (52,9%). Houve diferença de classificação do IMC entre as curvas propostas para portadores de SD e pela OMS. Houve associação entre consumo de vitamina E e ácidos graxos poli-insaturados. Conclusão: resultados mostraram que indivíduos com SD são, em sua maioria, considerados eutróficos para a idade quando avaliados pelas curvas específicas para SD. Avaliá-los de acordo com as curvas específicas para SD seria o recomendado para a prática dos profissionais da saúde, evitando-se diagnósticos precipitados de sobrepeso e/ou obesidade nessa população.

Growth curves in Down syndrome with congenital heart disease.

INTRODUCTION: To assess dietary habits, nutritional status and food frequency in children and adolescents with Down syndrome (DS) and congenital heart disease (CHD). Additionally, we attempted to compare body mass index (BMI) classifications according to the World Health Organization (WHO) curves and curves developed for individuals with DS. METHOD: Cross-sectional study including individuals with DS and CHD treated at a referral center for cardiology, aged 2 to 18 years. Weight, height, BMI, total energy and food frequency were measured. Nutritional status was assessed using BMI for age and gender, using curves for evaluation of patients with DS and those set by the WHO. RESULTS: 68 subjects with DS and CHD were evaluated. Atrioventricular septal defect (AVSD) was the most common heart disease (52.9%). There were differences in BMI classification between the curves proposed for patients with DS and those proposed by the WHO. There was an association between consumption of vitamin E and polyunsaturated fatty acids. CONCLUSION: Results showed that individuals with DS are mostly considered normal weight for age, when evaluated using specific curves for DS. Reviews on specific curves for DS would be the recommended practice for health professionals so as to avoid precipitated diagnosis of overweight and/or obesity in this population.

Lipid needs of preterm infants: updated recommendations.

Long-chain polyunsaturated fatty acids (LCPUFAs) are of nutritional interest because they are crucial for normal development of the central nervous system and have potential long-lasting effects that extend beyond the period of dietary insufficiency. Here we review the recent literature and current recommendations regarding LCPUFAs as they pertain to preterm infant nutrition. In particular, findings that relate to fetal accretion, LCPUFA absorption and metabolism, effects on development, and current practices and recommendations have been used to update recommendations for health care providers. The amounts of long-chain polyunsaturated fatty acids (LCPUFAs) used in early studies were chosen to produce the same concentrations as in term breast milk. This might not be a wise approach for preterm infants, however, particularly for very and extremely preterm infants, whose requirements for LCPUFAs and other nutrients exceed what is normally provided in the small volumes that they are able to tolerate. Recent studies have reported outcome data in preterm infants fed milk with a docosahexaenoic acid (DHA) content 2-3 times higher than the current concentration in infant formulas. Overall, these studies show that providing larger amounts of DHA supplements, especially to the smallest infants, is associated with better neurologic outcomes in early life. We emphasize that current nutritional management might not provide sufficient amounts of preformed DHA during the parenteral and enteral nutrition periods and in very preterm/very low birth weight infants until their due date, and that greater amounts than used routinely likely will be needed to compensate for intestinal malabsorption, DHA oxidation, and early deficit. Research should continue to address the gaps in knowledge and further refine adequate intake for each group of preterm infants.

Role of PUFAs, the precursors of endocannabinoids, in human obesity and type 2 diabetes.

Polyunsaturated fatty acids (PUFAs) serve as precursors of the endocannabinoids (ECs) that are bioactive lipids molecules. Recent studies revealed that ECs participate in several physiological and pathological processes including obesity and type 2 diabetes mellitus. Here we review the experimental and clinical aspects of the role of endocannabinoids in obesity and type 2 diabetes mellitus and the modification of the endocannabinoids by exogenously administered PUFAs. Based on these evidences, we propose that the endocannabinoid system (ECS) can be modulated by exogenous manipulation of PUFAs that could help in the prevention and management of human diseases such as obesity, metabolic syndrome and type 2 diabetes mellitus.

The function of very long chain polyunsaturated fatty acids in the pineal gland.

The mammalian pineal gland is a prominent secretory organ with a high metabolic activity. Melatonin (N-acetyl-5-methoxytryptamine), the main secretory product of the pineal gland, efficiently scavenges both the hydroxyl and peroxyl radicals counteracting lipid peroxidation in biological membranes. Approximately 25% of the total fatty acids present in the rat pineal lipids are represented by arachidonic acid (20:4n-6) and docosahexaenoic acid (22:6n-3). These very long chain polyunsaturated fatty acids play important roles in the pineal gland. In addition to the production of melatonin, the mammalian pineal gland is able of convert these polyunsaturated fatty acids into bioactive lipid mediators. Lipoxygenation is the principal lipoxygenase (LOX) activity observed in the rat pineal gland. Lipoxygenation in the pineal gland is exceptional because no other brain regions express significant LOX activities under normal physiological conditions. The rat pineal gland expresses both 12- and 15-lipoxygenase (LOX) activities, producing 12- and 15-hydroperoxyeicosatetraenoic acid (12- and 15-HpETE) from arachidonic acid and 14- and 17-hydroxydocosahexaenoic acid (14- and 17-HdoHE) from docosahexaenoic acid, respectively. The rat pineal also produces hepoxilins via LOX pathways. The hepoxilins are bioactive epoxy-hydroxy products of the arachidonic acid metabolism via the 12S-lipoxygenase (12S-LOX) pathway. The two key pineal biochemical functions, lipoxygenation and melatonin synthesis, may be synergistically regulated by the status of n-3 essential fatty acids.

Signalling pathways controlling fatty acid desaturation.

Microorganisms, plants and animals regulate the synthesis of unsaturated fatty acids (UFAs) during changing environmental conditions as well as in response to nutrients. Unsaturation of fatty acid chains has important structural roles in cell membranes: a proper ratio of saturated to UFAs contributes to membrane fluidity. Alterations in this ratio have been implicated in various disease states including cardiovascular diseases, immune disorders, cancer and obesity. They are also the major components of triglycerides and intermediates in the synthesis of biologically active molecules such as eicosanoids, which mediates fever, inflammation and neurotransmission. UFAs homeostasis in many organisms is achieved by feedback regulation of fatty acid desaturases gene transcription. Here, we review recently discovered components and mechanisms of the regulatory machinery governing the transcription of fatty acid desaturases in bacteria, yeast and animals.

Fatty acids and neurodevelopment.

Knowledge of the importance of docosahexaenoic acid (DHA), arachidonic acid (AA), and long-chain polyunsaturated fatty acids (LCPUFAs) in neurodevelopment was originally obtained from animal studies. These fatty acids are rapidly accreted in brain during the first postnatal year in animal and human infants, and they are found in high concentrations in breast milk. Reports of enhanced intellectual development in breast-fed children, and reports linking LCPUFA deficiency with neurodevelopmental disorders have stressed the physiological importance of DHA in visual and neural systems. In addition to high concentrations of fatty acids in breast milk, they are also present in fish and algae oil and have recently been added to infant formulas. Esterified poplyunsaturated fatty acids act in cellular membranes, in signal transduction, in neurotransmission, and in the formation of lipid rafts. Nonesterified polyunsaturated fatty acids can modulate gene expression and ion channel activities, thus becoming neuroprotective agents. The conversion of linoleic acid and alpha-linolenic acid into ARA and DHA have led to randomized clinical trials that have studied whether infant formulas supplemented with DHA or both DHA and ARA would enhance visual and cognitive development. This review gives an overview of fatty acids and neurodevelopment, focusing on the findings from these studies.

The ability of melatonin to counteract lipid peroxidation in biological membranes.

This paper reviews recent data relevant to the antioxidant effects of melatonin with special emphasis on the changes produced in polyunsaturated fatty acids located in the phospholipids of biological membranes. The onset of lipid peroxidation within cellular membranes is associated with changes in their physicochemical properties and with the impairment of protein functions located in the membrane environment. All cellular membranes are especially vulnerable to oxidation due to their high concentration of polyunsaturated fatty acids. These processes combine to produce changes in the biophysical properties of membranes that can have profound effects on the activity of membrane-bound proteins. This review deals with aspects for lipid peroxidation of biological membranes in general, but with some emphasis on changes of polyunsaturated fatty acids, which arise most prominently in membranes and have been studied extensively in our laboratory. The article provides current information on the effect of melatonin on biological membranes, changes in fluidity, fatty acid composition and lipid-protein modifications during the lipid peroxidation process of photoreceptor membranes and modulation of gene expression by the hormone and its preventive effects on adriamycin-induced lipid peroxidation in rat liver. Simple model systems have often been employed to measure the activity of antioxidants. Although such studies are important and essential to understand the mechanisms and kinetics of antioxidant action, it should be noted that the results of simple in vitro model experiments cannot be directly extrapolated to in vivo systems. For example, the antioxidant capacity of melatonin, one of the important physiological lipophilic antioxidants, in solution of pure triglycerides enriched in omega-3 polyunsaturated fatty acids is considerably different from that in subcellular membranes.

Receptores nucleares y regulacion de la expresion génica por acidos grasos poliinsaturados: algo mas que produccion de energía y esencialidad / Nuclear receptors and regulation of gene expression by polyunsaturated fatty acids: something more than energy production and essentiality

Regulation of gene expression is controlled by many molecules which acting in concert may activate o repress a gene or a group of genes. The regulation requires of different nuclear receptors which as homodimers or heterodimers interact with DNA trough the so called DNA interaction domains. The DNA-receptor binding is determined by the presence of specific ligands. The final action of this complex is the activation or repression of gene expression. A number of molecules may act as ligands of nuclear receptors, being fatty acids and their derivatives one of the most important ligands of nutritional origin. Polyunsaturated fatty acids, acting as ligands of nuclear receptors may modulate a wide variety of molecular responses, such as adipocite differentiation, modifying insulin resistance, regulating vascular pressure, inducing apoptosis of tumor cells, modifying carbohydrate metabolism, etc. This new function of fatty acids as important modulators of gene expression goes beyond to the production of energy and essentiality. This work reviews the structure and function of nuclear receptors and the regulatory role of fatty acids in gene expression.

La regulación de la expresión de los genes está determinada por una serie de moléculas que en su conjunto modulan la activación o la represión de un gen o de un grupo de genes. Esta regulación requiere de diferentes receptores nucleares, que en la forma de homodímeros o heterodímeros interactúan con el DNA en lugares específicos denominados dominios de interacción del DNA. La unión del receptor al DNA es determinada por la presencia de ligandos específicos. El resultado final de este complejo proceso produce la activación o la represión de la expresión de un gen. Numerosas moléculas actúan como ligandos de receptores nucleares, siendo los ácidos grasos y sus derivados uno de los ligandos de origen nutricional más importantes. Los ácidos grasos poliinsaturados, al actuar como ligandos de receptores nucleares desencadenan una gran variedad de respuestas celulares; inducen la diferenciación de adipocitos, modifican la resistencia a la insulina, regulan la presión vascular, inducen la apoptósis de células tumorales, modifican el metabolismo de los carbohidratos, etc. Esta nueva función de los ácidos grasos los identifica como importantes reguladores de los genes, con lo cual actualmente se les relaciona con algo más que la producción de energía y la esencialidad. Este trabajo revisa la estructura y función de los receptores nucleares y el rol regulador de los ácidos grasos en la expresión de los genes.

An overview of lipid peroxidation with emphasis in outer segments of photoreceptors and the chemiluminescence assay.

The onset of lipid peroxidation within cellular membranes is associated with changes in their physicochemical properties and with the impairment of protein functions located in the membrane environment. This article provides current information on the origin and function of polyunsaturated fatty acids in nature, lipid peroxidation of cellular membranes: enzymatic (lipoxygenases) and non-enzymatic. The latest knowledge on in vivo biomarkers of lipid peroxidation including isoprostanes, isofurans and neuroprostanes are discussed. A further focus is placed on analytical methods for studying lipid peroxidation in membranes with emphasis in chemiluminescence and its origin, rod outer segments of photoreceptors, the effect of antioxidants, fatty acid hydroperoxides and lipid protein modifications. Since rhodopsin, the major integral protein of rod outer segments is surrounded by phospholipids highly enriched in docosahexaenoic acid, the author proposes the outer segments of photoreceptors as an excellent model to study lipid peroxidation using the chemiluminescence assay since these membranes contain the highest concentration of polyunsaturated fatty acids of any vertebrate tissue and are highly susceptible to oxidative damage.

[Molecular mechanisms of action and health benefits of polyunsaturated fatty acids]. / Mecanismos moleculares de acción de los acidos grasos poliinsaturados y sus beneficios en la salud.

Essential polyunsaturated fatty acids (PUFAs), linoleic acid n6 (LA) and linolenic acid (ALA) n3 obtained from the diet are precursors of the long-chain polyunsaturated fatty acids (Lc-PUFAs) arachidonic acid (AA) and docosahexaenoic acid (DHA) respectively. Consumption of PUFAs is related with a better neurological and cognitive development in newborns. It has been demonstrated that consumption of n-6 and n-3 PUFAs decreases blood triglycerides by increasing fatty acid oxidation through activation of PPARalpha or by reducing the activation of SREBP-1 inhibiting lipogenesis. Dietary PUFAs activate PPARalpha and PPARgamma increasing lipid oxidation, and decreasing insulin resistance leading in a reduction of hepatic steatosis. Beneficial effects of PUFAs have been observed in humans and in animals models of diabetes, obesity, cancer, and cardiovascular diseases. It is important to promote the consumption of PUFAs. Main food sources of PUFAs n-6 are corn, soy and safflower oil, and for PUFAs n-3 are fish, soy, canola oil and, flaxseed. Finally FAO/WHO recommends an optimal daily intake of n6/n3 of 5-10:1.

Mecanismos moleculares de acción de los ácidos grasos poliinsaturados y sus beneficios en la salud / Molecular mechanisms of action and health benefits of polyunsaturated fatty acids

Essential polyunsaturated fatty acids (PUFAs), linoleic acid n6 (LA) and linolenic acid (ALA) n3 obtained from the diet are precursors of the long-chain polyunsaturated fatty acids (Lc-PUFAs) arachidonic acid (AA) and docosahexaenoic acid (DHA) respectively. Consumption of PUFAs is related with a better neurological and cognitive development in newborns. It has been demonstrated that consumption of n-6 and n-3 PUFAs decreases blood triglycerides by increasing fatty acid oxidation through activation of PPARα or by reducing the activation of SREBP-1 inhibiting lipogenesis. Dietary PUFAs activate PPARα and PPARγ increasing lipid oxidation, and decreasing insulin resistance leading in a reduction of hepatic steatosis. Beneficial effects of PUFAs have been observed in humans and in animals models of diabetes, obesity, cancer, and cardiovascular diseases. It is important to promote the consumption of PUFAs. Main food sources of PUFAs n-6 are corn, soy and safflower oil, and for PUFAs n-3 are fish, soy, canola oil and, flaxseed. Finally FAO/WHO recommends an optimal daily intake of n6/n3 of 5-10:1.

Los ácidos grasos poliinsaturados indispensables (AGPIs), ácido linoleico n-6 y ácido linolénico n-3 se obtienen a través de la dieta y son precursores de los ácidos grasos poliinsaturados de cadena larga (AGPIs-CL) araquidónico (AA) y docosahexaenoico (ADH), respectivamente. El consumo de AGPIs está relacionado con un mejor desarrollo cerebral fetal y cognoscitivo del recién nacido. Los AGPIs pueden reducir la concentración de triacilgliceroles en la sangre a través de la oxidación de ácidos grasos por medio de la activación de PPARα o a través de la represión de SREBP-1 que inhibe la lipogénesis. El consumo de AGPIs puede ser benéfico en el control de ciertas enfermedades como la diabetes mellitus y la obesidad en la que los AGPIs activan a PPARα estimulando la oxidación de lípidos y disminuyendo la resistencia a la insulina y la esteatosis hepática. En el caso del cáncer los AGPIs pueden servir como agentes citotóxicos para ciertas células tumorales. Debido a su efecto hipolipémico y a su efecto antiinflamatorio, los AGPIs podrían tener efectos benéficos en la prevención de enfermedades cardiovasculares. Las principales fuentes alimenticias de AGPIs n-6 son los aceites de maíz, de cártamo y de soya, y las de AGPIs n-3 son la linaza y los aceites de pescados, canola y de soya. Finalmente, la FAO/ OMS recomienda un consumo óptimo de AGPIs diario en una proporción n-6: n-3 de 5-10: 1/día.

Plausible mechanisms for effects of long-chain polyunsaturated fatty acids on growth.

A few studies conducted over the past decade suggest that formulas supplemented with long-chain polyunsaturated n-3 fatty acids may adversely affect growth of preterm infants. Others suggest that a high intake of alpha-linolenic acid (ALA; 18:3 n-3), the precursor of the long-chain polyunsaturated n-3 fatty acids, also may limit growth. The majority of studies, however, have not shown an effect of either long-chain polyunsaturated n-3 fatty acids or their precursor on growth. Nonetheless, the importance of growth during infancy and the possibility that these fatty acids may inhibit growth under some circumstances makes the issue worthy of further consideration. At the very least, plausible mechanisms for such an effect of n-3 PUFA on growth should be considered. These include (1) altered nutrient intake, absorption, and/or utilization; (2) low plasma and tissue contents of arachidonic acid (ARA;20:4 n-6); (3) an imbalance between n-6 and n-3 LCPUFA eicosanoid precursors and, hence, the eicosanoids produced from each; (4) altered membrane characteristics; and (5) effects on gene expression. Each of these is discussed. It is concluded that any or all are feasible but that none can be specifically implicated. Moreover, since few studies were designed specifically to assess growth, the reported effects of n-3 PUFA on growth could represent chance findings secondary to the suboptimal design. Furthermore, although additional data are needed for a definitive conclusion, the observed effects on growth, regardless of mechanism, does not appear to be biologically significant.

Efeito antioxidante dos compostos fenólicos de especiarias sobre os ácidos graxos das séries OMEGA 3 E OMEGA 6 / Antioxidant effect of phenolic compounds of spices on the OMEGA 3 and OMEGA 6

Dentro da perspectiva da utilização de compostos fenólicos como antioxidantes naturais para minimizar os efeitos in vitro e in vivo do processo oxidativo dos lípides insaturados, foi realizada a monitoração dietética de duas dietas ricas em lípides das séries "OMEGA"3 e "OMEGA"6 e a suplementação de um chá de uma mistura de especiarias, em ratos Wistar, com o objetivo de verificar a influência dos compostos fenólicos, presentes nas especiarias, sobre o metabolismo de ácidos graxos das séries "OMEGA"3 e "OMEGA"6. Extratos e frações das especiarias mostarda, canela e erva doce foram obtidos e tiveram suas atividades antioxidantes testadas em sitemas aquoso (co-oxidação de sustratos com o uso de ácido linoléico/"BETA"-caroteno)...

[Diet as a determinant of central nervous system development: role of essential fatty acids]. / La dieta como determinante del desarrollo del sistema nervioso central: rol de los ácidos grasos esenciales.

Nervous system is second to adipose tissue in containing the highest lipid concentration. Membrane phospholipids possess a high content of long chain polyunsaturated fatty acids (LCPUFA) of the n-3 and n-6 families, derived from the corresponding essential fatty acids. Docosahexaenoic acid (22:6n-3) is found in the highest concentrations in the gray matter and the photoreceptors of the retina. n-3 LCPUFA deficiency in infants, mainly if born preterm, modifies neural functions causing learning disabilities and visual function abnormalities. The adequate lipid nutrition of the mother before and during pregnancy and in breast feeding determine the lipid transfer of fatty acids to the fetus and infant, respectively. LCPUFA are conditionally essential in preterm infants, born with lower lipid depots. The formulation of infant formulas, mainly for preterm babies, should include adequate proportions of n-3 and n-6 LCPUFA.

Regulation of tumour cell fatty acid oxidation by n-6 polyunsaturated fatty acids.

Fatty acids have been shown to regulate the expression of mRNA for both lipogenic and glycolytic enzymes in rat liver. The role of fatty acids in the regulation of carnitine palmitoyltransferase (CPT) I and II activity in tumour cells was investigated. The polyunsaturated fatty acids, gamma-linolenic and arachidonic acid, caused 60-70% inhibition of tumour cell CPT I activity and 45-50% inhibition of [14C]-palmitic acid oxidation to 14CO2. These effects were blocked by the cyclooxygenase inhibitor, indomethacin. Prostaglandins E1 and E2 caused marked inhibition of both CPT I and CPT II activity and inhibition of cell proliferation. Prostaglandin E2 production by tumour cells was increased in the presence of arachidonic acid and inhibited when indomethacin was present. The proliferation of the HT29 cell line was unaffected as was its CPT I and II activity by both fatty acids and prostaglandins. CPT I mRNA expression was not inhibited by fatty acids, indeed it increased-in the presence of arachidonic acid and prostaglandin E1. These results strongly suggest that polyunsaturated n-6 fatty acids are able, via prostaglandin products, to regulate the CPT activity of certain tumour cells. This may have a considerable impact on mitochondrial beta-oxidation and cellular metabolism of fatty acids, reflected in the marked inhibition of cell proliferation by these fatty acids.

La dieta como determinante del desarrollo del sistema nervioso central: rol de los ácidos grasos asenciales / Diet as a determinant of the central nervous system development: role of essential fatty acids

El sistema nervioso central es el segundo tejido más rico en lípidos del organismo, luego del adiposo. Los fosfolípidos constituyentes de las membranas cerebrales poseen un alto contenido de ácidos grasos poliisaturados de cadena larga (AGPICL) de las familias n-3 y n-6, derivados de los respectivos ácidos grasos esenciales. Las mayores concentraciones de AGPICL en tejido nervioso corresponden al ácido docosahexaenoico (22:6n-3), en membranas de materia gris de corteza cerebral y fotoreceptores de retina. La deficiencia de AGPICL n-3 en recién nacidos, especialmente de pretérmino, modifica la función nerviosa, provocando dificuldades de aprendizaje y alteraciones de la función visual. El período de mayor acumulación de estos lípidos en cerebro es perinatal. Por esta razón, es importante la alimentación adecuada de la embarazada, antes y durante la gestación, y de la mujer que amamanta, que transfieren los AGPICL al feto y recién nacido, respectivamente. En niños de pretérmino, que nacen con menores reservas de AGPICL, estos tienen la calidad de condicionalmente esenciales. La formulación de las preparaciones destinadas a la alimentación de lactantes, especialmente si son prematuros, debe incluir AGPICL n-3 y n-6 en proporciones adecuadas.